Member Info for inanaco

You are just like Bermuda ... as the post clearly stated you can """speculate on the evidence""" !!
if you are not prepared to accept what is written then .. argue on the speculation presented as fact .. you then create an argument with yourself .. which is what you and Bermuda have done ................

the only thing you can speculate on is evidence

1/ collaboration has not been cancelled

2/ it was actually expanded by Modi3 and the Grand Ch. which all parties seem to be continuing with

3/ Dedicated staff employed.

the issue is the creation of a post through waffle ...

''That DATA may first appear in the form of the pre-clinical type via the BioNTech collaboration.

it's just stating the obvious by a different route to make it sound good rather than adding something

Suggest you join Tosh .. on his streaming Ch.

LOL ... i cannot have the same debate on two BB from Bermuda and Ruck both laying claim to the same posts ...who is actually who here ?

Bermuda

I did not claim anything i gave you 3 pieces of evidence to speculate on ..

"""" the only thing you can speculate on is evidence""""

this is you making an argument with yourself ...

as your unable to string a sentence you have to cut and paste Bermudas posts .. ?

it gets worse for you

so in other words

Nothing in the Goosed Post inspired you ...

LOL

If you can explain its "novel aspects " I am all ears

if you cannot .. then its worthless to you to !!

Tf if you go back to the original RNS announcing the Collaboration .. what has changed ? nothing .. so Goosed post is worthless .. the only thing you can speculate on is evidence

1/ collaboration has not been cancelled

2/ it was actually expanded by Modi3 and the Grand Ch. which all parties seem to be continuing with

3/ Dedicated staff employed.

the issue is the creation of a post through waffle ...

''That DATA may first appear in the form of the pre-clinical type via the BioNTech collaboration.

it's just stating the obvious by a different route to make it sound good rather than adding something

what is the actual point of this discussion ? .. or is it just another game of Tennis ...

Only what point has Goosed actually made that is novel ?

TF maybe its time you posted on the other BB rather than dragging these pointless posts from one BB to the other, especially the science posts which are not arriving filtered or explained by yourself and indeed the recent links are irrelevant without that explanation.

sorry to be abrupt but why allow Knowlesi and Ruck any movement to seed more clouds ?

Dragon Glass Nano ...
will know next week just how effective .. !! Epic

Tf ......... ?

""""Keytruda only works on T cells""""... nothing to do with electroporation, with the 1000,s that have taken Keytruda any issues with it have already been identified

Or you could just trust scancell and ichor .. after all ichor is signing up other big pharma with this MK2 version
so they must have something of interest, and the gun is being used in Europe, so whatever the FDA is looking at its not insurmountable. in that the mark 1 version worked well with SCIB1 and the action is similar but more automated.

It's in Both parties interest to trial with the new gun ... Scancell will be the first to prove it up in the US

and on the BioNtech Scancell is taking on staff for TCR, so commitments show that the collaboration must be showing something ... we wait deals

it probably involved a pre clinical test of some sort .. not just a written explanation

Say a lot when not a lot is required ...

less is more ...

example

https://twitter.com/i/status/1117995228248416257

RuckRover
Posts: 1,970
Opinion: No Opinion
Price: 5.15
RE: AnotherSun 18:00Inan,

I was looking for an SP estimate for Scancell rather than a price per patient for a different treatment.

as a final statement ..........

Price per patient ........... is the price the NHS will extend to dying cancer patients ... the reason why the price is so high is because of efficacy and Novartis are not charging for patients that fail the treatment

not sure what the type of treatment has to do with it ... nobody is looking at this as unacceptable profitability
when the goal is efficacy, toxicity and value for money

https://youtu.be/a9pVKWTZC9Y

If Scancell do some amazing deals as time progresses how will shareholders benefit unless they pay a dividend your post again makes no sense .. in all your posts you miss out upfront and stage payments working only on Royalties. So to say this will not be a dividend paying share is not correct.

not a debate ... just highlighting flaws

so your PD1 are about a 1/3 of that rate ..

30% efficacy

Basel, August 30, 2017 - Novartis announced today that the US Food and Drug Administration (FDA) has approved Kymriah(TM)(tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy

First-in-class therapy showed an 83% (52/63) overall remission rate in this patient population with limited treatment options and historically poor outcomes [1],[2].

Nice will pay only for the 83% ... at £266,000 per patient

in other words the NHS is including in the Failure rate

effectively that is your 100% efficacy price ..

another party agrees with me .........

""" hence efficacy is king """"

it sets the price

If your running a business reliant on "luck" ... that is not rec.

The industry developed vaccines up to its ability .. and it was not good enough .

I would argue the opposite that the fact that they cannot and we can ... what does that say ?

so rather than lowering Scancells long term value its raised it ... "the bigger the monopoly" bigger the reward